EOF 5.56% 3.8¢ ecofibre limited

Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study

  1. 7,742 Posts.
    lightbulb Created with Sketch. 1129
    Recce Pharmaceuticals (RCE) has been granted ethics approval to start a phase one/two study on patients with infected burn wounds sponsored by WA’s South Metropolitan Health Service with Fiona Stanley Hospital as the study site.

    Read the full article on The Market Herald.
 
watchlist Created with Sketch. Add EOF (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.